Live Analyst Rating Changes 1511 upgrades, downgrades & price-target moves · freshest Wall Street data, updated daily View live feed →
Analyst Tracker/Smedes Rose
Citi
Smedes Rose
Citi
Wall Street Analyst
★★★★☆
#702
on 13Foresight · ranked by our own returns
67%
Success Rate
+11.7%
Average Return
12 of 18 calls profitable · -6.4% vs benchmark
📈 Across the calls we could measure, roughly 67% of Smedes Rose's ratings turned a profit when each position was held for 1 year — averaging +11.7% per rating. These figures are computed by 13Foresight from historical prices, not supplied by the analyst.

Rating Distribution

1 Buy 0 Hold 0 Sell
Smedes's Stock Coverage 18 ratings · 2026-06-18
Company Date Position Consensus ⓘ Price Target ⓘ 1-Yr Return
PSA
Public Storage
 Aug 21, 2025 BUY Buy
-0.8% avg upside
29 analysts
$325.00
1.53% Upside
 +13.5%
EPR
EPR Properties
 Jun 06, 2025 HOLD Buy
+8.0% avg upside
21 analysts
 — +10.1%
MAR
Marriott International
 May 23, 2025 HOLD Buy
-19.7% avg upside
34 analysts
$285.00
28.69% Downside
 +44.5%
VICI
VICI Properties
 May 12, 2025 BUY Strong Buy
+27.9% avg upside
32 analysts
$36.00
28.57% Upside
 -3.9%
HST
Host Hotels & Resorts
 Mar 14, 2025 BUY Strong Buy
-11.3% avg upside
29 analysts
$19.00
23.75% Downside
 +31.5%
EXR
Extra Space Storage
 Jan 22, 2025 HOLD Buy
+3.5% avg upside
30 analysts
$165.00
12.72% Upside
 +0.2%
H
Hyatt Hotels
 Dec 23, 2024 HOLD Buy
-23.7% avg upside
32 analysts
$165.00
16.20% Downside
 +5.5%
CUBE
Cubesmart
 Sep 05, 2024 HOLD Buy
+3.8% avg upside
26 analysts
$50.00
21.43% Upside
 -14.4%
PK
Park Hotels & Resorts
 Jun 06, 2024 BUY Hold
+1.9% avg upside
23 analysts
$20.00
36.19% Upside
 -25.2%
GLPI
Gaming and Leisure
 May 17, 2024 BUY Strong Buy
+17.2% avg upside
34 analysts
$59.00
26.22% Upside
 +10.0%
SHO
Sunstone Hotel
 Mar 18, 2024 HOLD Hold
-8.0% avg upside
20 analysts
$11.50
3.04% Downside
 -9.8%
NSA
National Storage Affiliates
 Aug 24, 2023 HOLD Hold
-14.9% avg upside
25 analysts
$36.00
19.46% Downside
 +46.2%
DRH
Diamondrock
 Mar 27, 2023 HOLD Buy
-9.8% avg upside
22 analysts
$8.00
33.46% Downside
 +31.2%
PEB
Pebblebrook Hotel
 Feb 01, 2023 HOLD Hold
-16.0% avg upside
23 analysts
$16.50
14.82% Downside
 -7.6%
HLT
Hilton Worldwide Holdings
 Dec 13, 2022 HOLD Buy
-23.4% avg upside
34 analysts
$148.00
57.71% Downside
 +29.5%
RHP
Ryman
 Dec 14, 2021 BUY Strong Buy
-4.4% avg upside
18 analysts
$100.00
18.97% Downside
 +11.5%
DOC
Healthpeak Properties
 Aug 24, 2016 HOLD Buy
+18.4% avg upside
42 analysts
$38.00
89.15% Upside
 -14.1%
MTN
Vail Resorts
 Jun 02, 2014 BUY Buy
+20.0% avg upside
19 analysts
$85.00
37.91% Downside
 +52.2%
🔒 13 more ratings — with price targets, crowd consensus and our measured returns.
Sign in free to unlock See Pro plans
Free account unlocks every analyst's full coverage table.
Smedes Rose — Frequently Asked Questions
How accurate are Smedes Rose's stock ratings?
Based on the calls 13Foresight could measure, about 67% of Smedes's ratings were profitable over a one-year hold, with an average return of +11.7% per rating, or -6.4% versus the S&P 500. We score every analyst the same way, from historical prices.
How is Smedes ranked on 13Foresight?
Smedes Rose is currently ranked #702 with a 4-star rating. Our rank blends hit rate, average return versus the market, and how many calls we have to judge — so a long, consistent record outweighs a few lucky picks. It is our own calculation, updated daily.
Which stocks does Smedes cover?
Smedes most recently has ratings on PSA, EPR, MAR, VICI, HST, EXR, H, CUBE, PK, GLPI, SHO, NSA and 6 more. See the full coverage table above for positions, price targets and our measured returns.
Where can I see other analyst ratings?
Browse the full analyst leaderboard to compare Wall Street analysts ranked by their measured performance, success rate and average return.

Disclaimer: 13Foresight compiles analyst ratings and price targets from publicly available sources. Performance metrics, rankings and star ratings shown here are calculated independently by 13Foresight from historical market prices and may differ from figures published elsewhere. This information may be incomplete, delayed or inaccurate, is provided for research and informational purposes only, and is not investment advice. The underlying ratings and opinions are those of the respective analysts and their firms; 13Foresight accepts no liability for any decisions made based on this data.